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Antibacterial fluoromicas: a novel delivery 
medium 
 
Bekir Dizman, Jonathan C. Badger, Mohamed O. Elasri, Lon J. Mathias1 
 
Department of Polymer Science and Department of Biological Sciences, The 





Antibacterial fluoromicas were prepared by ion-exchanging fluoromicas with 
different antibacterial agents including various quaternary ammonium compounds, 
AgNO3, and norfloxacin.  Antibacterial activities of the ion-exchanged fluoromicas were 
determined against Staphylococcus aureus and Escherichia coli.  Minimum inhibitory 
concentration (MIC) and zone of inhibition (ZOI) tests were performed to determine both 
antibacterial effectiveness and mode of action associated with the fluoromicas.  All 
treated fluoromicas showed excellent antibacterial activities against both types of 
bacteria.  The antibacterial activities of treated fluoromicas were found to be either better 
than or the same as those of neat antibacterial agents.  The repeated antibacterial activity 
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1. Introduction 
A substantial amount of work has been carried out on designing biomaterials, 
specifically polymers and surfaces that are inherently antibacterial.  Most of these 
surfaces are generated by attaching antibacterial compounds directly to a substrate or 
incorporating antibacterial agents as pendant groups on polymer chains via covalent 
bonds.  These materials have a wide variety of applications including but not limited to 
medical devices, clothing, countertops, and coatings.  A few examples of antibacterial 
agents that have been used in new biomaterials pertinent to this research are quaternary 
ammonium compounds, fluoroquinolones, and silver nitrate (Baveja et al., 2004; Catauro 
et al., 2004; Dizman et al., 2005; Hume et al., 2004; Oie et al., 2004; Piddock et al., 2001; 
Samuel and Guggenbichler, 2004). 
Quaternary ammonium compounds (QACs) are antibacterial agents used as both skin 
antiseptics and disinfectants (Borman, 2002; Chauhan et al., 2004; Lee et al., 2004; 
Richard et al., 1997).  They generally contain a positively charged hydrophilic 
ammonium group and a long hydrophobic alkyl chain.  It is believed that QACs kill 
bacteria by disrupting cell walls and/or inner bilipid membranes causing the cytoplasmic 
membrane contents of the cell to leak out (Birnie et al., 2000; Lee et al., 2004).  The most 
active QACs contain alkyl chains that are between 8 and 18 carbons in length; e.g. 
compounds with 16 carbon alkyl chains are effective against both Gram-positive and 
Gram-negative bacteria (Birnie et al., 2000; Borman, 2002; Sauvet et al., 2000). 
Another major class of antibacterial agents are antibiotic drugs.  Norfloxacin is a 
broad spectrum chemotherapeutic antibiotic in the fluoroquinolone class.  It forms a three 
membered complex with DNA, DNA gyrase, and DNA topoisomerase IV, which are 
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responsible for relieving torsional strain in DNA during transcription and replication.  
The complex causes a variety of adverse interactions within the cell that ultimately lead 
to cell death (Dizman et al., 2005, Drlica, 1999). 
Silver has also been used for years as a broad spectrum antibiotic for burn victims and 
in the eyes of newborns (Melaiye et al., 2004; Richard and Samuel, 1997).  The Ag+, 
active form, precipitates proteins, inhibits a variety of enzymes, and has a negative effect 
on transport systems in membranes (Dibrov et al., 2002; Richard and Samuel, 1997). 
Silver has been incorporated onto glass surfaces, zeolites, and into catheters where it 
shows very promising antibacterial activity (Catauro et al., 2004; Rivera-Garza et al., 
2000; Samuel and Guggenbichler, 2004).  The structures of the antibacterial compounds 























Scheme 1.  Typical antibacterial compounds 
 
Clays are phyllosillicates composed of stacked sheets of nanosized, sandwich-like 
structures made primarily of silicon, oxygen and other metals.  The interlayer of each 
sheet contains Al, Mg and related elements along with negative charges that are balanced 
with exchangeable cations on the surface such as Na+, K+, and Li+.  The amount of 
exchangeable cations per mass unit is called the cation exchange capacity (CEC).  This 
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unique electrostatic arrangement allows the surface cations of clays to be exchanged with 
organic cations.  Dispersion of such organoclays is useful in enhancing the mechanical 
properties of polymers (Heinz and Suter, 2004; Heinz et al., 2003). 
There are relatively few publications pertaining to organically-modified clay minerals 
showing antibacterial activity.  The previous work that exists has focused on QAC 
modified clays and their uses in water purification and cosmetics (Alther, 2001; 
Guilbeaux, 1988; Herrera et al., 2000; Herrera et al., 2004).  
In this study, we report specifically on the antibacterial activity of fluoromicas 
exchanged with various QACs containing 16 carbon alkyl chains, AgNO3, and 
norfloxacin.  
2. Materials and Methods 
2.1.   Materials  
Norfloxacin, 1,4-diazabicyclo[2.2.2.] octane (DABCO), 3-quinuclidinol, and 
cetyltrimethylammonium bromide (CTAB) were obtained from Sigma-Aldrich Chemical 
Company.  SOMASIF ME-100 synthetic fluoromica (CEC 70-110 mequiv./ 100g 
(Murayama et al., 2002; Tamura et al., 2000) was purchased from UNICOOP Japan.  
Silver nitrate (AgNO3) and all solvents were purchased from Sigma-Aldrich Chemical 
Company, Acros Chemical Company, or Fisher.  Triptic soy agar (TSA) and triptic soy 
broth (TSB) were purchased from Difco Laboratories.  Bacterial strains used for 
antibacterial activity tests included S. aureus and E. coli strain.  The strains were kept at – 
80 oC in a freezer.  C16-D and C16-Q were prepared by reacting DABCO and 
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quinuclidinol, respectively, with 1-bromohexadecane using a literature procedure 
(Dizman et al., 2004). 
2.2.   Measurements 
13C and 1H NMR solution spectra were recorded on a Bruker AC-200 spectrometer at 
room temperature using CDCl3 and D2O as solvents with tetramethylsilane (TMS) as 
internal reference.  Fourier transform infrared spectra (FTIR) were obtained using a 
Mattson 5000 spectrometer using pressed KBr pellets.  Thermal analyses were performed 
on a TA Instruments 9900 analyzer equipped with a 952 thermal gravimetric analyzer 
cell using heating rates of 20 oC/min to 800 C in air.  Antibacterial assays were 
incubated in a Gyromax 737 shaker at 37 ºC with a gyration speed of 220 rpm.  
2.3.   Preparation of Antibacterial Fluoromicas 
Exact amounts of fluoromica and antibacterial compound used for preparation of each 
nanocomposite are provided in Table 1.  A sample of fluoromica was weighed and 
suspended in 100 mL of deionized water using a magnetic stir bar.  The antibacterial 
compound, whose amount was determined using the formula below, was then added to 
the suspension to provide an excess of cations for the exchange.  The suspension was 
then stirred vigorously at ambient temperature for 24 h. 
Amount of Antibacterial Agent
(Amount of Clay)
100 g
x(CEC)x (MW of Antibacterial Agent) x (1.1)
 
CEC is the cation exchange capacity for clay, which is 110 mequiv. for fluoromica.  
For the clay exchanged with norfloxacin, 5% HCl solution was added into the flask 
containing norfloxacin to protonate the amine function of norfloxacin and make it both 
 6 
water soluble and exchangeable with the fluoromica cations.  After 24 h, the suspensions 
of the fluoromicas treated with QACs were filtered and resuspended in 100 mL of 
deionized water for 1 h.  The suspensions of fluoromicas with silver and norfloxacin were 
filtered, washed, resuspended in deionized water, and centrifuged a minimum of three 
times.  The solid products obtained were filtered, dried in a vacuum oven at ambient 
temperature, and reground with a mortar and pestle. 







Mass of compound used 
(g) 
AgNO3 0.28 169.87 0.06 
NOR 0.26 319.33 0.10 
CTAB 4.95 364.45 1.91 
C16-D 0.22 417.51 0.11 
C16-Q 0.21 432.52 0.11 
 
2.4.   Antibacterial Assessment 
2.4.1. Preparation of bacterial cultures 
Broth cultures of S. aureus and E. coli were prepared from streaks on agar plates.  A 
sterile wire loop was used to take a small sample of bacteria from the agar plate.  Each 
bacterial sample was placed into a culture tube containing 5 mL of TSB.  The inoculated 
tubes were incubated at 37 ºC with shaking for 24 h.  Concentrations of bacteria were 
measured by optical density at 600 nm.  A standard curve was used to estimate the 
number of colony forming units (CFUs) used in the experiments (data not shown). 
2.4.2. Antibacterial assessment of neat and treated clays  
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Two samples of each neat and treated clays were suspended in TSB at a concentration 
of 5 mg/mL in culture tubes.  Each sample was then tested for antibacterial effectiveness 
against both S. aureus and E. coli by inoculating the tubes with 105 CFUs of bacteria.  
The culture tubes were incubated at 37 C with shaking for 24 h.  A 100 μL aliquot was 
then taken from each tube, spread on a TSA plate and incubated at 37 C for 24 h.  The 
TSA plates were examined for bacterial growth and compared with the plates of control 
samples.  After the first trial, the samples were washed 3 times with 10 mL portions of 
deionized water.  The fluoromicas were suspended and centrifuged in each wash.  A 
second trial was then run using the washed samples under the same conditions.    
2.4.3. Zone of inhibition (ZOI) test 
Both parent compounds and their treated fluoromica counterparts were used for 
testing.  Agar plates were inoculated with 106 CFUs of S. aureus (in 100 μL of TSB).  
Small, circular wells were dug into the agar plates using the back end of a 100 μL pipette 
tip.  2 mg of each sample was suspended or dissolved in 100 μL of TSB and placed into 
the wells.  The plates were then placed in an oven at 37 ºC for 24 h.  The diameter of the 
zone of inhibition was then measured to the nearest mm.   
2.4.4. ZOI test for CTAB treated clay washed with 1% NaCl 
A 100 mL solution of 1% aqueous NaCl was prepared and a 1 g sample of CTAB 
treated clay was suspended using high agitation stirring with a magnetic stir bar for a 
period of 30 min.  The fluoromica was then filtered using suction filtration and washed 
with small portions of distilled water.  A small portion of the solid sample was collected 
for ZOI test and the process was repeated 3 additional times using the remaining sample 
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to give a total of 4 samples.  The samples were dried and TGA was run on each one to 
determine the percentage of organic material remaining on the fluoromica. 
A TSA plate was inoculated with 106 CFUs of S. aureus and small circular wells were 
dug into the agar using the back end of a 100 μL pipette tip.  Washed samples (5 mg) 
were each suspended in 250 μL of TSB and a portion of each suspension was added to 
the dug wells in the agar plate.  The plate was then incubated at 37 ºC for 24 h.  Results 
were examined on a qualitative basis for growth. 
2.4.5. Minimum inhibitory concentration (MIC) test for treated clays   
The MIC values of treated clays were determined by the broth dilution method using 
serial twofold dilutions in TSB.  The concentrations ranged from 256 μg/mL to 0.5 
μg/mL.  Each solution in the series was mixed with 105 CFU of the test organism in a 96-
well microtiter plate.  The 96-well plate was incubated at 37 oC for 24 h.  The MIC test 
was repeated at least three times for each treated clay.   
3. Results 
3.1.  Verification and evaluation of cation exchanges with fluoromica  
The amounts of the antibacterial compounds used for the cation exchanges were 
determined using the formula given in the experimental section.  A 1.1x excess of each 
antibacterial agent was used in order to achieve the maximum cation exchange.   
FTIR and TGA were run on all exchanged samples to verify success of the cation 
exchange.  Figure 1 shows the FTIR spectra for neat fluoromica, norfloxacin-treated 
fluoromica, and CTAB-treated fluoromica.  The presence of symmetric and 
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antisymmetric streching peaks of CH, CH2, and CH3 groups at 2900-3000 cm
-1 and their 
deformation peaks at 1470 cm-1 indicate that the exchange with CTAB cations was 
successful.  Similar spectra were obtained when C16-D and C16-Q were used for the 
treatment of the fluoromica.  All the norfloxacin peaks were observed in the spectrum of 


















Figure 1.  FTIR spectra of fluoromica, norfloxacin-treated fluoromica, and CTAB-
treated fluoromica 
 
Thermogravimetric analysis (TGA) was used to determine the organic content of the 
modified fluoromica samples.  The TGA thermograms in Figure 2 show two mass losses 
for each compound.  The first mass loss between 0 and 100 C corresponds to loss of 
water.  The second mass loss observed for all samples except the silver-treated 
fluoromica, showed a loss that corresponded to degradation of organic materials bound to 
the fluoromica.  The table inside Figure 2 shows both water and organic content for all 
samples. 
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Figure 2.  TGA thermograms of organically treated fluoromicas (interior table shows 
water and organic content of the treated fluoromicas) 
 
Table 2 shows the amount of cation exchange expressed as a percentage.  TGA data 
from the table inside Figure 2 was used for each calculation.  First, the mass losses 
associated with water and organic material in the samples were subtracted from the total 
sample mass yielding the mass of the fluoromica in the samples.  Next, the molar 
equivalent of exchangeable cations was calculated by multiplying the CEC value of the 
fluoromica by the mass of fluoromica.  Finally, the number of moles of organic material 
on the surface of clay was calculated from the mass loss data and divided by the number 
of exchangeable sites giving the percent success of the exchange.  TGA data for the QAC 
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treated fluoromicas indicated that more than 100% of the CEC had been exchanged with 
organic material except for norfloxacin.  One of the reasons for such high percentages is 
that there are associations that are nonionic in nature.  Additional QACs may simply be 
associating with already bound organics via hydrophobic interactions.  Additionally, 
water, organic material, or other impurities in the original fluoromica or reagents, 
incomplete eliminations in TGA, variable CEC, and other experimental errors can result 
in high exchange rates.  The cation exchange percentage was however a little bit lower 
for norfloxacin.  This might be due to the aromatic structure of norfloxacin, which can 
make its diffusion into the clay interlayers more difficult.  Moreover, norfloxacin has a 
zwitterionic nature and this can result in a weaker binding to clay compared to the other 
strongly ionic agents. 
Table 2.  Cation exchange percentages for compounds  






CEC value of 110 mequiv / 100g was used 
Calculations were based on mass loss data from TGA 
 
3.2.   Antibacterial assessment of neat and treated clays 
The initial screening of treated clays showed that all silver, quaternary ammonium, 
and norfloxacin treated clays kill both E. coli and S. aureus at a concentration of 5 
mg/mL, whereas neat clay did not show any antibacterial activity.  After washing the 
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treated clay samples with distilled water, the samples maintained their activity and were 
just as effective in the second trials.  
3.2.1.  Zone of inhibition (ZOI) test results   
The results from the zone of inhibition tests are given in Table 3.  The diameter of the 
zone of inhibition and the amount of diffusion from the edge of each hole in the agar 
plate are given in mm.  Both the treated clays and parent antibacterials by themselves 
showed some degree of diffusion.  The zone of inhibition for each of the treated clays 
was consistently less than each of the antibacterials alone, consistent with lower available 
concentrations of clay-bound agents.  The QAC and silver samples showed far less 
diffusion as compared with the norfloxacin samples.  The ZOI results for the neat 
norfloxacin and norfloxacin-treated fluoromica samples are shown in Figure 3. 
Table 3.  Zone of inhibition test results 
Compound 
Initial Hole Diameter 
(mm) 




CTAB 8 14 3 
Fluoromica + CTAB 8 9 0.5 
C16-D 8 13 2.5 
Fluoromica + C16-D 8 9 0.5 
C16-Q 8 11 1.5 
Fluoromica + C16-Q 8 9 0.5 
Ag+ 8 14 3 
Fluoromica + Ag+ 8 11 1.5 
NOR 8 37 14.5 






Figure 3.  ZOI test results for norfloxacin (top) and NOR-treated fluoromica (bottom) 
 
3.2.2.  ZOI test results of CTAB treated fluoromica washed with 1% NaCl   
The TGA data for the washed samples indicate that even after 4 washings with a 1% 
NaCl solution the amount of organic material bound the clay remained the same (see 
Table 4).  This is consistent with the qualitative results from the zone of inhibition test in 
which the diameter of inhibition for each of these washed samples was the same. 
Table 4.  Organic and water content of CTAB-treated fluoromica after each wash with 
1% NaCl  
Wash # Sample mass (mg) Water Content (%) Organic content (%) 
1 8.32 9.38 25.16 
2 9.38 4.93 24.81 
3 8.49 5.92 25.36 




3.2.3.   Minimum inhibitory concentration (MIC) test results for treated clays   
MIC values of all treated clays against S. aureus and E. coli are given in Tables 5 and 
6, respectively.  Some samples showed a consistent MIC value for each of the three trials 
while others showed more variation.  MIC values for samples that contained variations 
are given as a range.  The concentrations of available antibacterials in each treated 
fluoromica sample were calculated by multiplying the percentage of total organic 
material in the composite by the MIC value of the composite.  These MIC values were 
compared with the MICs of the neat antibacterial agents (last column).  The MICs for 
CTAB, C16-Q, C16-D, silver, and norfloxacin were determined using the same 
procedures.  When the last two columns (amount of antibacterial agent in the treated 
fluoromicas at the MIC values and antibacterial activity of neat compounds, respectively) 
in Tables 5 and 6 are compared it is observed that all treated clays either showed better 
activities than or were as effective as the parent compounds except norfloxacin-treated 
clay. 








MIC of antibacterial 
compound (μg/mL)
CTAB 26.78 2 - 8 0.5 - 2 2
C16-Q 27.88 4 1 2
C16-D 27.11 4 - 8 1 - 2 2
Ag+ - 32 - 64 - 16









MIC of treated       
mica (μg/mL)
Available antibacterial  
concentration (μg/mL)
MIC of antibacterial 
compound (μg/mL)
CTAB 26.78 2 to 4 0.5 - 1 4
C16-Q 27.88 2 to 4 0.5 - 1 8
C16-D 27.11 4 1 4
Ag+ - 4 to 64 - 8
NOR 11.25 32 3.5 0.5
 
4.   Discussion 
The results obtained for the organically and silver-modified clays indicate that all 
samples show very good antibacterial activities.  Two possible mechanisms can be 
responsible for the observed antibacterial activity.  The first mechanism involves the 
immobilization of the bacteria on the surface of the clay.  The affinity of bacteria for 
fluoromica can be as a result of two critical interactions: electrostatic attraction and 
hydrophobic interaction.  Under physiological conditions, both fluoromica and bacterial 
cell surfaces are negatively charged (Nzengung et al., 1996; Stotzky et al., 1989).  This 
prevents the attraction of bacteria to fluoromica.  However, the exchange of clays with 
positively charged antibacterial agents at greater than the CEC produces a material that is 
positively charged.  The charge of these exchanged clays enhances their ability to attract 
bacteria through electrostatic interactions.  Introduction of norfloxacin and QACs with 
long alkyl chains also provides a hydrophobic character to the clays.  These hydrophobic 
moieties on the clay surface can interact with the lipophilic components of the bacterial 
cell walls, such as lipoproteins, liposaccharides, and phospholipids.   As a result of these 
two types of interactions, the bacteria are brought in close association to the surface of 
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the exchanged clay, where the antibacterial agents exert their activity on the bacteria.  
This mechanism was first proposed by Herrera at al. and supported by the 
cetylpyridinium desorption studies.  In the desorption studies, they found that the 
antibacterial activity was localized at the modified clay surfaces, as the washed clay 
particles produced reductions in bacterial counts, whereas the washed solutions did not.  
They also obtained electron micrographs of the treated clays, which showed that bacteria 
were adherent to the surfaces of the cetylpyridinium-exchanged clays (Herrera et al., 
2000; Herrera et al., 2004).  In our study, the antibacterial activities for all treated clays 
were maintained in the second trials as well as after several washings.  The organic 
contents of the treated clays obtained from TGA thermograms also indicated that the 
amount of the organic content stayed pretty much the same after several washings.  These 
are good indicators for the fact that the antibacterial activity occurs on the clay surface.  
The MIC values obtained against S. aureus and E. coli show very interesting trends.  The 
minimum inhibitory concentrations of the antibacterial agents in the QAC-treated clays 
are at or below the MIC values of the original QACs.  The explanation for this fact is that 
since QACs are in close proximity when they are attached to the clay surface, they show 
synergistic better activity against bacteria through enhanced electrostatic and 
hydrophobic interactions with bacterial cell surfaces. 
The second mechanism involves the dissociation of the antibacterial agents from the 
clay surface and exertion of their antibacterial effects on bacteria in suspension.  The 
zone of inhibition studies indicate that there are inhibition zones for all treated clays.  
This is a sign of the diffusion of the antibacterial agents from treated clays into the agar.  
However, the inhibition zones were very small in diameter for all treated clays except 
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norfloxacin-treated clay.  This could be because the norfloxacin diffuses more efficiently 
than the other compounds and/or because norfloxacin is less tightly bound to the surface 
of the clay.  These results indicate that at least a small amount of antibacterial is being 
released into the TSA.  TSA contains sodium chloride and other organic compounds, 
which could facilitate the exchange of cations on the fluoromica surface in the reverse 
direction.   
5.  Conclusions 
In this work, various antibacterial compounds were efficiently exchanged with 
cations in fluoromica in order to obtain antibacterial fluoromicas.  The treated 
fluoromicas showed excellent antibacterial activities.  The antibacterial activity of the 
treated fluoromicas is mainly due to the attraction of the bacteria to the clay surface 
through electrostatic and hydrophobic interactions and exertion of the antibacterial effect 
of the antibacterial agents bound to the surface on bacteria.  The small and continuous 
release of antibacterial agents from treated clays is other minor mechanism of activity.  
Since these materials show very good antibacterial activities, they offer excellent 
potential for long term effectiveness for surfaces, paints, water filtration, or as powdered 
delivery of antibacterials. 
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